Literature DB >> 30860011

Cardiac Involvement in Travelers with Enteric Fever.

Asaf Biber1, Eyal Nof2, Eli Schwartz1.   

Abstract

Data regarding cardiac involvement in enteric fever among travelers are scarce. In this retrospective study, 59 patients were hospitalized with enteric fever during 2004-2017 and 28 had cardiac workups. Among those, four had evidence of cardiac involvement, including clinical myocarditis, electrocardiogram changes, or troponin elevation. Cardiac involvement was higher among patients infected with Salmonella Typhi than with Salmonella Paratyphi A (P = 0.08), with a significant relative risk of 6 (95% CI: 1.15-31.22, P = 0.03). Time from symptoms onset to effective treatment was longer for patients with cardiac involvement (13 versus 7.15 days, P < 0.05). It seems that cardiac involvement in enteric fever is not uncommon in travelers. Such involvement seems to be more common in patients with delay of effective treatment to the second week of illness. Although fatal or complicated cases are rare in travelers, the cardiac complication may be an important contributor to morbidity and mortality in this group.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30860011      PMCID: PMC6493970          DOI: 10.4269/ajtmh.18-0775

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  21 in total

1.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

Authors:  Alida L P Caforio; Sabine Pankuweit; Eloisa Arbustini; Cristina Basso; Juan Gimeno-Blanes; Stephan B Felix; Michael Fu; Tiina Heliö; Stephane Heymans; Roland Jahns; Karin Klingel; Ales Linhart; Bernhard Maisch; William McKenna; Jens Mogensen; Yigal M Pinto; Arsen Ristic; Heinz-Peter Schultheiss; Hubert Seggewiss; Luigi Tavazzi; Gaetano Thiene; Ali Yilmaz; Philippe Charron; Perry M Elliott
Journal:  Eur Heart J       Date:  2013-07-03       Impact factor: 29.983

2.  Encephalitis in a traveller with typhoid fever: efficacy of corticosteroids.

Authors:  Guillaume Mellon; Anne-Line Eme; Benjamin Rohaut; Florence Brossier; Loïc Epelboin; Eric Caumes
Journal:  J Travel Med       Date:  2017-09-01       Impact factor: 8.490

Review 3.  Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides.

Authors:  Micha Maeder; Thomas Fehr; Hans Rickli; Peter Ammann
Journal:  Chest       Date:  2006-05       Impact factor: 9.410

4.  Infectious disease following travel to developed regions: a snapshot of presentations to an Australian travel medicine clinic.

Authors:  George Drewett; Karin Leder
Journal:  J Travel Med       Date:  2016-08-05       Impact factor: 8.490

Review 5.  Typhoid and paratyphoid fever in travellers.

Authors:  Bradley A Connor; Eli Schwartz
Journal:  Lancet Infect Dis       Date:  2005-10       Impact factor: 25.071

6.  [Complications and the proximate causes of death in typhoid].

Authors:  A N Bobin; N D Klochkov; N V Bogomolova
Journal:  Voen Med Zh       Date:  1993-01

7.  Clinical Importance of Salmonella Paratyphi A Infection to Enteric Fever in Nepal.

Authors: 
Journal:  J Travel Med       Date:  1995-09-01       Impact factor: 8.490

Review 8.  Typhoid fever.

Authors:  John Wain; Rene S Hendriksen; Matthew L Mikoleit; Karen H Keddy; R Leon Ochiai
Journal:  Lancet       Date:  2014-10-21       Impact factor: 79.321

Review 9.  Pathophysiology of sepsis-induced myocardial dysfunction.

Authors:  Xiuxiu Lv; Huadong Wang
Journal:  Mil Med Res       Date:  2016-09-27

10.  Open label comparative trial of mono versus dual antibiotic therapy for Typhoid Fever in adults.

Authors:  Niv Zmora; Sudeep Shrestha; Ami Neuberger; Yael Paran; Rajendra Tamrakar; Ashish Shrestha; Surendra K Madhup; T R S Bedi; Rajendra Koju; Eli Schwartz
Journal:  PLoS Negl Trop Dis       Date:  2018-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.